Final Phase II Data Support Infigratinib in Chemotherapy-refractory Cholangiocarcinoma Harboring FGFR2 Fusions

Default Digital Object Group ◽

10.1200/adn.21.200438 ◽

2021 ◽

Keyword(s):

Phase Ii ◽

Final Phase ◽

Data Support

Download Full-text

Final Phase I-Phase II interim report : expedited site characterization, Morrill, Kansas.

10.2172/890562 ◽

2005 ◽

Author(s):

L M LaFreniere

Keyword(s):

Phase I ◽

Phase Ii ◽

Site Characterization ◽

Interim Report ◽

Final Phase

Download Full-text

Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.2060 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 2060-2060

Author(s):

K. Peters ◽

A. Desjardins ◽

J. J. Vredenburgh ◽

B. Dryman ◽

S. Gururangan ◽

...

Keyword(s):

Imatinib Mesylate ◽

Phase Ii ◽

Phase Ii Study ◽

Low Grade Glioma ◽

Low Grade ◽

Final Phase ◽

Study Results

Download Full-text

Rapid processing of positioning information for handheld gamma camera. Final Phase II report

10.2172/809470 ◽

2002 ◽

Author(s):

Irving Weinberg

Keyword(s):

Phase Ii ◽

Gamma Camera ◽

Final Phase ◽

Rapid Processing

Download Full-text

Final phase II trial results of Sorafenib plus Capecitabine (SorCape) in previously treated metastatic colorectal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e15035 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e15035-e15035

Author(s):

Thomas J. George ◽

Alison Marguerite Ivey ◽

Karen Colleen Daily ◽

Long H. Dang ◽

Scott Watson ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Final Phase ◽

Previously Treated

Download Full-text

Environmentally benign manufacturing of compact disc stampers [Final Phase II report]

10.2172/770616 ◽

1999 ◽

Author(s):

Keyword(s):

Phase Ii ◽

Compact Disc ◽

Environmentally Benign ◽

Final Phase ◽

Environmentally Benign Manufacturing

Download Full-text

Final Phase II report : QuickSite(R) investigation, Everest, Kansas.

10.2172/1013960 ◽

2003 ◽

Author(s):

L. M. LaFreniere

Keyword(s):

Phase Ii ◽

Final Phase

Download Full-text

Final phase II report : QuickSite® investigation, Adams, Nebraska.

10.2172/1188315 ◽

2002 ◽

Author(s):

Jacqueline C. Burton

Keyword(s):

Phase Ii ◽

Final Phase

Download Full-text

Final phase I report and phase II work plan : expedited site characterization, Agenda, Kansas.

10.2172/1188321 ◽

1997 ◽

Author(s):

Jacqueline C. Burton

Keyword(s):

Phase I ◽

Phase Ii ◽

Site Characterization ◽

Final Phase ◽

Work Plan

Download Full-text

Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e15165 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e15165-e15165

Author(s):

S. T. Tagawa ◽

A. Saran ◽

N. H. Akhtar ◽

S. Goel ◽

G. Mileo ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Advanced Renal Cell Carcinoma ◽

Final Phase

Download Full-text

Final phase II safety and efficacy results of study MC0452: Phase I/II trial of CCI 779 and bevacizumab in advanced renal cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4548 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4548-4548 ◽

Cited By ~ 5

Author(s):

J. R. Merchan ◽

H. C. Pitot ◽

R. Qin ◽

G. Liu ◽

T. R. Fitch ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Phase Ii ◽

Renal Cell ◽

Advanced Renal Cell Carcinoma ◽

Final Phase ◽

Safety And Efficacy

Download Full-text